A detailed history of Paloma Partners Management CO transactions in Viatris Inc stock. As of the latest transaction made, Paloma Partners Management CO holds 21,619 shares of VTRS stock, worth $240,835. This represents 0.01% of its overall portfolio holdings.

Number of Shares
21,619
Holding current value
$240,835
% of portfolio
0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.32 - $12.13 $223,108 - $262,238
21,619 New
21,619 $250,000
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $201,856 - $242,335
17,911 New
17,911 $213,000
Q2 2022

Aug 15, 2022

SELL
$9.95 - $12.27 $66,854 - $82,442
-6,719 Reduced 17.49%
31,700 $332,000
Q1 2022

May 16, 2022

SELL
$9.81 - $15.4 $1.98 Million - $3.1 Million
-201,538 Reduced 83.99%
38,419 $418,000
Q4 2021

Feb 14, 2022

BUY
$12.09 - $14.68 $2.9 Million - $3.52 Million
239,957 New
239,957 $3.25 Million

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $13.5B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.